Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance. 2005

Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
Chugai Pharmaceutical Co. Ltd., Fuji-Gotemba Research Laboratories, 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan. kikuchiysf@chugai-pharm.co.jp

An assay method using a surface plasmon resonance (SPR) biosensor has been developed that allows quantitative measurement of the specific antibody concentration in crude materials. By injecting non-labeled antibody samples onto a biosensor surface on which antigen was immobilized at high densities, the concentration of active antibodies can be accurately measured. To clarify applicability of this method to pharmacokinetic studies, the concentration of active antibodies in mouse plasma was measured for 4 h after injection of antibodies in mice. Although this period of measurement might be insufficient for determining the pharmacokinetics of blood pool clearance, this method has some advantages over conventional methods in measurement of single-chain antibody fragment (scFv) concentrations. Using the SPR biosensor, scFv and antibodies without epitope tag peptides were easily detected in real time, requiring as little as 20 mul of blood sample. Moreover, from the apparent dissociation rate in the dissociation phase of the sensorgrams, we could identify whether the antibody fragments existed as bivalent or monovalent in animal blood. We also evaluated the antigen binding activity of the scFvs against human CD47 and found scFvs had slightly weak affinity to their antigen (K(D), about 10 nM) compared with F(ab')2 and Fab' fragments (K(D), about 3-4 nM). This assay method promises to be a convenient tool for quality control, screening, and simple pharmacokinetic analysis of antibody fragments and other recombinant proteins not having epitope tags.

UI MeSH Term Description Entries
D007128 Immunoglobulin Fragments Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques. Antibody Fragment,Antibody Fragments,Ig Fragment,Ig Fragments,Immunoglobulin Fragment,Fragment, Antibody,Fragment, Ig,Fragment, Immunoglobulin,Fragments, Antibody,Fragments, Ig,Fragments, Immunoglobulin
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020349 Surface Plasmon Resonance A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film's surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding. Plasmon Resonance, Surface,Plasmon Resonances, Surface,Resonance, Surface Plasmon,Resonances, Surface Plasmon,Surface Plasmon Resonances

Related Publications

Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
January 2004, Reviews in medical virology,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
August 1997, Current opinion in biotechnology,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
July 2018, Biochemistry and biophysics reports,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
July 1994, Journal of chromatography. A,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
January 2010, Journal of immunological methods,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
January 2017, Journal of biochemistry,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
January 2017, Methods in molecular biology (Clifton, N.J.),
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
January 2000, Methods in molecular biology (Clifton, N.J.),
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
May 1996, Biochemistry,
Yasufumi Kikuchi, and Shinsuke Uno, and Masahiko Nanami, and Yasushi Yoshimura, and Shin-ichiro Iida, and Naoshi Fukushima, and Masayuki Tsuchiya
February 2019, Advanced pharmaceutical bulletin,
Copied contents to your clipboard!